본문 바로가기
KERD
논문KCI 등재

ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Objective: Genetic variations in the gene encoding zinc finger protein 804A gene (ZNF804A) have been associated with major depression and bipolar disorder. In this work we focused on the potential influence of ZNF804A variations on the risk of developing specific sub-phenotypes as well as the individual response to available treatments. Methods: We used two samples of different ethnic origin: a Korean sample, composed by 242 patients diagnosed with major depression and 132 patients diagnosed with bipolar disorder and 326 healthy controls; an Italian sample composed 151 major depression subjects, 189 bipolar disorder subjects and 38 outpatients diagnosed for a primary anxiety disorder. Results: Our analyses reported an association of rs1344706 with psychotic phenotype in the cross-diagnostic pooled sample (geno p = 4.15 × 10−4, allelic p = 1.06 × 10−4). In the cross-diagnosis Italian sample but not in the Korean one, rs7597593 was involved with depressive symptoms improvement after treatment (geno p = 0.025, allelic p = 0.007). Conclusion: The present study evidenced the role of ZNF804A alterations in symptoms improvement after treatment. Both manic and depressive symptoms seem to be modulated by ZNF804A, though the latter was observed in the bipolar pooled sample only. The role of this factor is likely related to synaptic development and maintenance; however, further analyses will be needed to better understand the molecular mechanics involved with ZNF804A.

Abstract

Objective: Genetic variations in the gene encoding zinc finger protein 804A gene (ZNF804A) have been associated with major depression and bipolar disorder. In this work we focused on the potential influence of ZNF804A variations on the risk of developing specific sub-phenotypes as well as the individual response to available treatments. Methods: We used two samples of different ethnic origin: a Korean sample, composed by 242 patients diagnosed with major depression and 132 patients diagnosed with bipolar disorder and 326 healthy controls; an Italian sample composed 151 major depression subjects, 189 bipolar disorder subjects and 38 outpatients diagnosed for a primary anxiety disorder. Results: Our analyses reported an association of rs1344706 with psychotic phenotype in the cross-diagnostic pooled sample (geno p = 4.15 × 10−4, allelic p = 1.06 × 10−4). In the cross-diagnosis Italian sample but not in the Korean one, rs7597593 was involved with depressive symptoms improvement after treatment (geno p = 0.025, allelic p = 0.007). Conclusion: The present study evidenced the role of ZNF804A alterations in symptoms improvement after treatment. Both manic and depressive symptoms seem to be modulated by ZNF804A, though the latter was observed in the bipolar pooled sample only. The role of this factor is likely related to synaptic development and maintenance; however, further analyses will be needed to better understand the molecular mechanics involved with ZNF804A.

참고문헌 (51)

  1. Dedic N, "Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood", Mol Psychiatry, 23, pp.533~543 (2018)
  2. Rao S, "Common variants in CACNA1C and MDD susceptibility : a comprehensive meta-analysis", Am J Med Genet B Neuropsychiatr Genet, 171, pp.896~903 (2016)
  3. He K, "CACNA1C, schizophrenia and major depressive disorder in the Han Chinese population", Br J Psychiatry, 204, pp.36~39 (2014)
  4. Krishnan V, "Linking molecules to mood : new insight into the biology of depression", Am J Psychiatry, 167, pp.1305~1320 (2010)
  5. Vogelzangs N, "Association of depressive disorders, depression characteristics and antidepressant medication with inflammation", Transl Psychiatry, 2, pp.e79~ (2012)
  6. Arias B, "DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy", J Affect Disord, 168, pp.91~97 (2014)
  7. Perlis RH, "Pharmacogenomic testing and personalized treatment of depression", Clin Chem, 60, pp.53~59 (2014)
  8. Cross-Disorder Group of the Psychiatric Genomics C, "Identification of risk loci with shared effects on five major psychiatric disorders : a genome-wide analysis", Lancet, 381, pp.1371~1379 (2013)
  9. Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium, "Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes", Cell, 173, pp.1705~1715.e16 (2018)
  10. Lett TA, "ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype", World J Biol Psychiatry, 12, pp.392~397 (2011)
  11. Williams HJ, "Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries", Hum Mol Genet, 20, pp.387~391 (2011)
  12. Ou J, "The schizophrenia susceptibility gene ZNF804A confers risk of major mood disorders", World J Biol Psychiatry, 18, pp.557~562 (2017)
  13. Donohoe G, "The psychosis susceptibility gene ZNF804A : associations, functions, and phenotypes", Schizophr Bull, 36, pp.904~909 (2010)
  14. Gamsjaeger R, "Sticky fingers : zinc-fingers as protein-recognition motifs", Trends Biochem Sci, 32, pp.63~70 (2007)
  15. O’Donovan MC, "Genetics of psychosis;insights from views across the genome", Hum Genet, 126, pp.3~12 (2009)
  16. Lencz T, "A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes", Neuropsychopharmacology, 35, pp.2284~2291 (2010)
  17. Esslinger C, "Neural mechanisms of a genome-wide supported psychosis variant", Science, 324, pp.605~ (2009)
  18. Esslinger C, "Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A", Neuroimage, 54, pp.2514~2523 (2011)
  19. Rasetti R, "Altered cortical network dynamics : a potential intermediate phenotype for schizophrenia and association with ZNF804A", Arch Gen Psychiatry, 68, pp.1207~1217 (2011)
  20. Johnson MB, "Functional and evolutionary insights into human brain development through global transcriptome analysis", Neuron, 62, pp.494~509 (2009)
  21. O’Donovan MC, "Identification of loci associated with schizophrenia by genome-wide association and follow-up", Nat Genet, 40, pp.1053~1055 (2008)
  22. Riley B, "Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample", Mol Psychiatry, 15, pp.29~37 (2010)
  23. Steinberg S, "Expanding the range of ZNF804A variants conferring risk of psychosis", Mol Psychiatry, 16, pp.59~66 (2011)
  24. Williams HJ, "Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder", Mol Psychiatry, 16, pp.429~441 (2011)
  25. Fabbri C, "Neuroplasticity and second messenger pathways in antidepressant efficacy : pharmacogenetic results from a prospective trial investigating treatment resistance", Eur Arch Psychiatry Clin Neurosci, 267, pp.723~735 (2017)
  26. Mössner R, "The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms", Eur Arch Psychiatry Clin Neurosci, 262, pp.193~197 (2012)
  27. Zhang J, "Association analysis of ZNF804A(zinc finger protein 804A)rs1344706 with therapeutic response to atypical antipsychotics in first-episode Chinese patients with schizophrenia", Compr Psychiatry, 53, pp.1044~1048 (2012)
  28. Schwab SG, "Association of rs1344706 in the ZNF804A gene with schizophrenia in a case", control sample from Indonesia, 2013, pp.147, 46~52
  29. Zhang R, "Population-based and family-based association studies of ZNF804A locus and schizophrenia", Mol Psychiatry, 16, pp.360~361 (2011)
  30. Zhang R, "Further evidence for the association of genetic variants of ZNF804A with schizophrenia and a meta-analysis for genome-wide significance variant rs1344706", Schizophr Res, 141, pp.40~47 (2012)
  31. Tao R, "Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder : a novel transcript fetally regulated by the psychosis risk variant rs1344706", JAMA Psychiatry, 71, pp.1112~1120 (2014)
  32. Huang L, "A comprehensive meta-analysis of ZNF804A SNPs in the risk of schizophrenia among Asian populations", Am J Med Genet B Neuropsychiatr Genet, 171B, pp.437~446 (2016)
  33. Wei Q, "ZNF804A rs1344706 is associated with cortical thickness, surface area, and cortical volume of the unmedicated first episode schizophrenia and healthy controls", Am J Med Genet B Neuropsychiatr Genet, 168B, pp.265~273 (2015)
  34. Wickramasinghe A, "Associations between the schizophrenia susceptibility gene ZNF804A and clinical outcomes in psychosis", Transl Psychiatry, 5, pp.e698~ (2015)
  35. Zhang C, "ZNF804A genetic variation confers risk to bipolar disorder", Mol Neurobiol, 53, pp.2936~2943 (2016)
  36. Sun Y, "Association between variants of zinc finger genes and psychiatric disorders : systematic review and meta-analysis", Schizophr Res, 162, pp.124~137 (2015)
  37. Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 59(Suppl 20), pp.22~33 (1998)
  38. Mandelli L, "The impact of a single nucleotide polymorphism in SIGMAR1 on depressive symptoms in major depressive disorder and bipolar disorder", Adv Ther, 34, pp.713~724 (2017)
  39. Calabrò M, "Genes involved in neurodevelopment, neuroplasticity, and bipolar disorder : CACNA1C, CHRNA1, and MAPK1", Neuropsychobiology, 74, pp.159~168 (2016)
  40. Fabbri C, "PPP3CC gene : a putative modulator of antidepressant response through the B-cell receptor signaling pathway", Pharmacogenomics J, 14, pp.463~472 (2014)
  41. Zimmerman M, "Severity classification on the Hamilton Depression Rating Scale", J Affect Disord, 150, pp.384~388 (2013)
  42. Schosser A, "European Group for the Study of Resistant Depression(GSRD)--where have we gone so far : review of clinical and genetic findings", Eur Neuropsychopharmacol, 22, pp.453~468 (2012)
  43. Thompson E, "Hamilton Rating Scale for Anxiety(HAM-A)", Occup Med(Lond), 65, pp.601~ (2015)
  44. Young RC, "A rating scale for mania : reliability, validity and sensitivity", Br J Psychiatry, 133, pp.429~435 (1978)
  45. de Castro-Catala M, "The genome-wide associated candidate gene ZNF804A and psychosis-proneness : evidence of sex-modulated association", PLoS One, 12, pp.e0185072~ (2017)
  46. Wang Q, "Genetic analysis of common variants in the ZNF804A gene with schizophrenia and major depressive disorder", Psychiatr Genet, 28, pp.1~7 (2018)
  47. Chen X, "Effect of rs1344706 in the ZNF804A gene on the brain network", Neuroimage Clin, 17, pp.1000~1005 (2017)
  48. Barrett JC, "Haploview : analysis and visualization of LD and haplotype maps", Bioinformatics, 21, pp.263~265 (2005)
  49. Rao S, "Genetic association of rs1344706 in ZNF804A with bipolar disorder and schizophrenia susceptibility in Chinese populations", Sci Rep, 7, pp.41140~ (2017)
  50. Desmet FO, "Human Splicing Finder : an online bioinformatics tool to predict splicing signals", Nucleic Acids Res, 37, pp.e67~ (2009)
  51. Fornito A, "Connectomic intermediate phenotypes for psychiatric disorders", Front Psychiatry, 3, pp.32~ (2012)

관련 논문AI추천

Abelson Helper Integration Site-1 Gene Variants on Major Depressive Disorder and Bipolar Disorder배치운, 이수정, 한창수, Alessandro Serretti, Ashwin A Patkar, Beatrice Balzarro, Diana De Ronchi, Prakash S. Masand, Siegfried Alberti, Stefano Porcelli대한신경정신의학회 · PSYCHIATRY INVESTIGATION2014 · 제11권 제4호Leveraging genetic overlap between irritability and psychiatric disorders to identify genetic variants of major psychiatric disorders박웅양, 원홍희, Ahn Yeeun, Andreassen Ole A., Cha Soojin, Cho Hyunbin, Cho Min Young, Jung Kyeongmin, Jung Sang-Hyuk, Kim Beomsu, Kim Dan Say, Kim Hyejin, Kim Jaeyoung, Kim Jinho, Kim Soyeon, Ko Hyunwoong, Lee Dong June, Lee Hyewon, Myung Woojae, O`Connell Kevin S., Park Tae Hwan, Shim Injeong, Yoon Joohyun생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Relationship between Polygenic Risk Score and the Hypnotics in Bipolar I DisorderBun-Hee Lee, Hyeon Woo Lee, John R. Kelsoe, Tatyana Shekhtman, Young-Min Park대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2024 · 제22권 제4호유럽인 자료로 산출된 양극성 장애 다유전자 위험 점수의 한국인 양극성 장애 환자에의 적용백지현, 이동빈, 조윤지, 조은영, 최민준, 홍경수대한신경정신의학회 · 신경정신의학2021 · 제60권 제3호Possible Modulatory Role of ARC Gene Variants in Mood DisordersAlessandro Serretti, Ashwin Patkar, Changsu Han, Chi Un Pae, Concetta Crisafulli, Daniel Souery, Julien Mendlewicz, Laura Mandelli, Marco Calabrò, Prakash Masand, Sheng Min Wang, Soo-Jung Lee대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제1호A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode PsychosisBenedicto Crespo-Facorro, Diana Tordesillas-Gutiérrez, Ignacio Mata, Javier Vázquez-Bourgon, José Luis Vázquez-Barquero, Paula Suárez Pinilla, Roberto Roiz-Santiáñez, Rosa Ayesa-Arriola대한신경정신의학회 · PSYCHIATRY INVESTIGATION2014 · 제11권 제2호

이 간행물의 다른 논문 (17건)